CND LIFE SCIENCES CLOSES SEED 2 ROUND SERIES AND REACHES $8 MILLION IN CAPITAL RAISED
PHOENIX, February 1, 2022 /PRNewswire/ — CND Life Sciences, Inc. (www.cndlifesciences.com), an innovative medical diagnostics company pioneering the detection, visualization and quantification of protein deposits in cutaneous nerve fibers, today announced the closing of a $5.0 million Seed Series 2 Funding Round. This follow-on round comes a year after itsRead More →